Close Menu

NEW YORK (GenomeWeb) — Akonni Biosystems said today that it has received a three-year, $3 million Phase II Small Business Innovation Research (SBIR) contract from the National Institutes of Health to continue work on a device to purify DNA from sputum for tuberculosis testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.